trial
as of 2026-07-01Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI)
NCTId NCT01394757
at a glance
— · Completed
Enrollment 52 (actual)
Sponsored by Medical University of Vienna
Primary completion 2012-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
52 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2011-08
Primary completion
2012-08
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Indications
Sponsors
Medical University of ViennaLead Sponsor
Investigators
1
Rupert Lanzenberger, A/Prof., MDPrincipal Investigator
Sites
1 total
Vienna, Austria
Facts & assertions
4 sourced
Enrollment
52
Phase
NA
Primary Completion Date
2012-08
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
investigator